The correlation between etoposide (VP-16) cytotoxicity and the induction of sister chromatid exchanges (SCEs) suggested that the promotion of DNA recombination events may be crucial for the activity of antitopoisomerase drugs. To further evaluate this hypothesis, we investigated the correlation between VP-16 induction of SCEs, chromosomal aberrations and cell cycle alterations in lymphoblastoid cell lines derived from patients affected by ataxia telangiectasia(AT), whose cells are known as hypersensitive to the cytotoxic and clastogenic activity of DNA topoisomerase II inhibitors. Our present study has shown that AT homozygous and heterozygous cell lines exposed to low VP-16 concentrations, although hypersensitive to the induction of chromo...
7 p.-7fig.-1tab. - Pérez et al., 1994The administration of 150 nM etoposide, an inhibitor of DNA top...
MastersDNA topoisomerase II (topo II) inhibitors were selected for testing in the present study base...
Etoposide is a cancer drug that induces strand breaks in cellular DNA by inhibiting topoisomerase II...
The correlation between etoposide (VP-16) cytotoxicity and the induction of sister chromatid exchang...
Topoisomerase II (topo II) inhibitors are commonly used as chemotherapy to treat multiple types of c...
Doxonrbicin, ellipticine and etoposide are antineoplastic drugs with topoisomerase II inhibitory act...
Etoposide (ETO), a drug used for the treatment of human tumors, is associated with the development o...
ICRF-187 (Cardioxane™, Chiron) is a catalytic inhibitor of DNA topoisomerase II (Topo II), proposed ...
Frequencies of symmetrical and asymmetrical exchange aberrations induced by two inhibitors of topois...
Although the application of the concept of a threshold to risk assessment is widespread, there remai...
The objective of the current investigation is to determine whether non-toxic doses of the catalytic ...
Topoisomerase II (topo II) is an essential nuclear enzyme that plays a role in maintaining DNA topol...
In mammalian cells, the H2AX histone is rapidly phosphorylated upon the induction of DNA double stra...
Frequencies of symmetrical and asymmetrical exchange aberrations induced by two inhibitors of topois...
Topoisomerase II inhibitors are effective chemotherapeutic agents in the treatment of cancer, in spi...
7 p.-7fig.-1tab. - Pérez et al., 1994The administration of 150 nM etoposide, an inhibitor of DNA top...
MastersDNA topoisomerase II (topo II) inhibitors were selected for testing in the present study base...
Etoposide is a cancer drug that induces strand breaks in cellular DNA by inhibiting topoisomerase II...
The correlation between etoposide (VP-16) cytotoxicity and the induction of sister chromatid exchang...
Topoisomerase II (topo II) inhibitors are commonly used as chemotherapy to treat multiple types of c...
Doxonrbicin, ellipticine and etoposide are antineoplastic drugs with topoisomerase II inhibitory act...
Etoposide (ETO), a drug used for the treatment of human tumors, is associated with the development o...
ICRF-187 (Cardioxane™, Chiron) is a catalytic inhibitor of DNA topoisomerase II (Topo II), proposed ...
Frequencies of symmetrical and asymmetrical exchange aberrations induced by two inhibitors of topois...
Although the application of the concept of a threshold to risk assessment is widespread, there remai...
The objective of the current investigation is to determine whether non-toxic doses of the catalytic ...
Topoisomerase II (topo II) is an essential nuclear enzyme that plays a role in maintaining DNA topol...
In mammalian cells, the H2AX histone is rapidly phosphorylated upon the induction of DNA double stra...
Frequencies of symmetrical and asymmetrical exchange aberrations induced by two inhibitors of topois...
Topoisomerase II inhibitors are effective chemotherapeutic agents in the treatment of cancer, in spi...
7 p.-7fig.-1tab. - Pérez et al., 1994The administration of 150 nM etoposide, an inhibitor of DNA top...
MastersDNA topoisomerase II (topo II) inhibitors were selected for testing in the present study base...
Etoposide is a cancer drug that induces strand breaks in cellular DNA by inhibiting topoisomerase II...